Search Media Items

Anna Bowen, MD1; Dana Eikmeier, MPH2; Pamela Talley, MD2,3; Alicia Siston, PhD4; Shamika Smith, MPH4; Jacqueline Hurd, MPH1; Kirk Smith, PhD2; Fe Leano, MS2; Amelia Bicknese1; J. Corbin Norton1; Davina Campbell, MS1 (Author affiliations at end of text).

On June 2, 2015, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).

Grace D. Appiah, MD1; Lenee Blanton, MPH1; Tiffany D'Mello, MPH1; Krista Kniss, MPH1; Sophie Smith, MPH1; Desiree Mustaquim, MPH1; Craig Steffens, MPH1; Rosaline Dhara, MPH1; Jessica Cohen, MPH1; Sandra S. Chaves, MD1; Joseph Bresee, MD1; Teresa Wallis, MS1; Xiyan Xu, MD1; Anwar Isa Abd Elal1; Larisa Gubareva, PhD1; David E.

Kevin C. Scott, MD1; Eboni M. Taylor, PhD2; Blain Mamo, MPH3; Nathaniel D.

In this video, genetic counselor Joyce Turner, MSC, CGC, explains what the BRCA1 and BRCA2 genes are and how a mutation in either gene can lead to cancer. She also discusses how genetic counseling and testing can help women make informed decisions about their health. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/cancer/videos/breast/BringYourBrave/Genetic_Counselor/WhatIsBRCAGeneMutation/WhatIsBRCAGeneMutation_lowRes.mp4

Your patient’s insurance plan may cover these services 100%--with no co-pays or deductibles for your patient to pay. Many insurers require the clinical provider to code the services in particular ways that often vary by insurer. Diagnosis codes may be required for proper reimbursement for some services. This is not intended to be a comprehensive list, and not all insurers accept all of these coding configurations.

The United States Preventive Services Task Force recommends that women with specific patterns of breast, ovarian, tubal, or peritoneal cancer in their family history consider genetic counseling and testing for BRCA gene mutations.

CDC launched Bring Your Brave in 2015 to provide information about breast cancer to women younger than age 45.